Polyphyllin I alleviates neuroinflammation after cerebral ischemia–reperfusion injury via facilitating autophagy-mediated M2 microglial polarization

Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from pro-inflammatory to anti-inflammatory phenotype is a promising therapeutic strategy for the treatment of cerebral ischemia. Polyphyllin I (PPI), a steroi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular medicine (Cambridge, Mass.) Jg. 30; H. 1; S. 59 - 18
Hauptverfasser: Kang, Chunyang, Sang, Qiuling, Liu, Dingxi, Wang, Libo, Li, Jia, Liu, Xiaoyang
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London BioMed Central 14.05.2024
Springer Nature B.V
BMC
Schlagworte:
ISSN:1528-3658, 1076-1551, 1528-3658
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from pro-inflammatory to anti-inflammatory phenotype is a promising therapeutic strategy for the treatment of cerebral ischemia. Polyphyllin I (PPI), a steroidal saponin, shows multiple bioactivities in various diseases, but the potential function of PPI in cerebral ischemia is not elucidated yet. In our study, the influence of PPI on cerebral ischemia–reperfusion injury was evaluated. Mouse middle cerebral artery occlusion (MCAO) model and oxygen–glucose deprivation and reoxygenation (OGD/R) model were constructed to mimic cerebral ischemia–reperfusion injury in vivo and in vitro. TTC staining, TUNEL staining, RT-qPCR, ELISA, flow cytometry, western blot, immunofluorescence, hanging wire test, rotarod test and foot-fault test, open-field test and Morris water maze test were performed in our study. We found that PPI alleviated cerebral ischemia–reperfusion injury and neuroinflammation, and improved functional recovery of mice after MCAO. PPI modulated microglial polarization towards anti-inflammatory M2 phenotype in MCAO mice in vivo and post OGD/R in vitro. Besides, PPI promoted autophagy via suppressing Akt/mTOR signaling in microglia, while inhibition of autophagy abrogated the effect of PPI on M2 microglial polarization after OGD/R. Furthermore, PPI facilitated autophagy-mediated ROS clearance to inhibit NLRP3 inflammasome activation in microglia, and NLRP3 inflammasome reactivation by nigericin abolished the effect of PPI on M2 microglia polarization. In conclusion, PPI alleviated post-stroke neuroinflammation and tissue damage via increasing autophagy-mediated M2 microglial polarization. Our data suggested that PPI had potential for ischemic stroke treatment.
AbstractList Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from pro-inflammatory to anti-inflammatory phenotype is a promising therapeutic strategy for the treatment of cerebral ischemia. Polyphyllin I (PPI), a steroidal saponin, shows multiple bioactivities in various diseases, but the potential function of PPI in cerebral ischemia is not elucidated yet. In our study, the influence of PPI on cerebral ischemia–reperfusion injury was evaluated. Mouse middle cerebral artery occlusion (MCAO) model and oxygen–glucose deprivation and reoxygenation (OGD/R) model were constructed to mimic cerebral ischemia–reperfusion injury in vivo and in vitro. TTC staining, TUNEL staining, RT-qPCR, ELISA, flow cytometry, western blot, immunofluorescence, hanging wire test, rotarod test and foot-fault test, open-field test and Morris water maze test were performed in our study. We found that PPI alleviated cerebral ischemia–reperfusion injury and neuroinflammation, and improved functional recovery of mice after MCAO. PPI modulated microglial polarization towards anti-inflammatory M2 phenotype in MCAO mice in vivo and post OGD/R in vitro. Besides, PPI promoted autophagy via suppressing Akt/mTOR signaling in microglia, while inhibition of autophagy abrogated the effect of PPI on M2 microglial polarization after OGD/R. Furthermore, PPI facilitated autophagy-mediated ROS clearance to inhibit NLRP3 inflammasome activation in microglia, and NLRP3 inflammasome reactivation by nigericin abolished the effect of PPI on M2 microglia polarization. In conclusion, PPI alleviated post-stroke neuroinflammation and tissue damage via increasing autophagy-mediated M2 microglial polarization. Our data suggested that PPI had potential for ischemic stroke treatment.
Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from pro-inflammatory to anti-inflammatory phenotype is a promising therapeutic strategy for the treatment of cerebral ischemia. Polyphyllin I (PPI), a steroidal saponin, shows multiple bioactivities in various diseases, but the potential function of PPI in cerebral ischemia is not elucidated yet. In our study, the influence of PPI on cerebral ischemia-reperfusion injury was evaluated. Mouse middle cerebral artery occlusion (MCAO) model and oxygen-glucose deprivation and reoxygenation (OGD/R) model were constructed to mimic cerebral ischemia-reperfusion injury in vivo and in vitro. TTC staining, TUNEL staining, RT-qPCR, ELISA, flow cytometry, western blot, immunofluorescence, hanging wire test, rotarod test and foot-fault test, open-field test and Morris water maze test were performed in our study. We found that PPI alleviated cerebral ischemia-reperfusion injury and neuroinflammation, and improved functional recovery of mice after MCAO. PPI modulated microglial polarization towards anti-inflammatory M2 phenotype in MCAO mice in vivo and post OGD/R in vitro. Besides, PPI promoted autophagy via suppressing Akt/mTOR signaling in microglia, while inhibition of autophagy abrogated the effect of PPI on M2 microglial polarization after OGD/R. Furthermore, PPI facilitated autophagy-mediated ROS clearance to inhibit NLRP3 inflammasome activation in microglia, and NLRP3 inflammasome reactivation by nigericin abolished the effect of PPI on M2 microglia polarization. In conclusion, PPI alleviated post-stroke neuroinflammation and tissue damage via increasing autophagy-mediated M2 microglial polarization. Our data suggested that PPI had potential for ischemic stroke treatment.Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from pro-inflammatory to anti-inflammatory phenotype is a promising therapeutic strategy for the treatment of cerebral ischemia. Polyphyllin I (PPI), a steroidal saponin, shows multiple bioactivities in various diseases, but the potential function of PPI in cerebral ischemia is not elucidated yet. In our study, the influence of PPI on cerebral ischemia-reperfusion injury was evaluated. Mouse middle cerebral artery occlusion (MCAO) model and oxygen-glucose deprivation and reoxygenation (OGD/R) model were constructed to mimic cerebral ischemia-reperfusion injury in vivo and in vitro. TTC staining, TUNEL staining, RT-qPCR, ELISA, flow cytometry, western blot, immunofluorescence, hanging wire test, rotarod test and foot-fault test, open-field test and Morris water maze test were performed in our study. We found that PPI alleviated cerebral ischemia-reperfusion injury and neuroinflammation, and improved functional recovery of mice after MCAO. PPI modulated microglial polarization towards anti-inflammatory M2 phenotype in MCAO mice in vivo and post OGD/R in vitro. Besides, PPI promoted autophagy via suppressing Akt/mTOR signaling in microglia, while inhibition of autophagy abrogated the effect of PPI on M2 microglial polarization after OGD/R. Furthermore, PPI facilitated autophagy-mediated ROS clearance to inhibit NLRP3 inflammasome activation in microglia, and NLRP3 inflammasome reactivation by nigericin abolished the effect of PPI on M2 microglia polarization. In conclusion, PPI alleviated post-stroke neuroinflammation and tissue damage via increasing autophagy-mediated M2 microglial polarization. Our data suggested that PPI had potential for ischemic stroke treatment.
Abstract Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from pro-inflammatory to anti-inflammatory phenotype is a promising therapeutic strategy for the treatment of cerebral ischemia. Polyphyllin I (PPI), a steroidal saponin, shows multiple bioactivities in various diseases, but the potential function of PPI in cerebral ischemia is not elucidated yet. In our study, the influence of PPI on cerebral ischemia–reperfusion injury was evaluated. Mouse middle cerebral artery occlusion (MCAO) model and oxygen–glucose deprivation and reoxygenation (OGD/R) model were constructed to mimic cerebral ischemia–reperfusion injury in vivo and in vitro. TTC staining, TUNEL staining, RT-qPCR, ELISA, flow cytometry, western blot, immunofluorescence, hanging wire test, rotarod test and foot-fault test, open-field test and Morris water maze test were performed in our study. We found that PPI alleviated cerebral ischemia–reperfusion injury and neuroinflammation, and improved functional recovery of mice after MCAO. PPI modulated microglial polarization towards anti-inflammatory M2 phenotype in MCAO mice in vivo and post OGD/R in vitro. Besides, PPI promoted autophagy via suppressing Akt/mTOR signaling in microglia, while inhibition of autophagy abrogated the effect of PPI on M2 microglial polarization after OGD/R. Furthermore, PPI facilitated autophagy-mediated ROS clearance to inhibit NLRP3 inflammasome activation in microglia, and NLRP3 inflammasome reactivation by nigericin abolished the effect of PPI on M2 microglia polarization. In conclusion, PPI alleviated post-stroke neuroinflammation and tissue damage via increasing autophagy-mediated M2 microglial polarization. Our data suggested that PPI had potential for ischemic stroke treatment.
ArticleNumber 59
Author Liu, Dingxi
Kang, Chunyang
Liu, Xiaoyang
Wang, Libo
Li, Jia
Sang, Qiuling
Author_xml – sequence: 1
  givenname: Chunyang
  surname: Kang
  fullname: Kang, Chunyang
  organization: Department of Neurology, China-Japan Union Hospital of Jilin University
– sequence: 2
  givenname: Qiuling
  surname: Sang
  fullname: Sang, Qiuling
  organization: Department of Neuroelectrophysiology, China-Japan Union Hospital of Jilin University
– sequence: 3
  givenname: Dingxi
  surname: Liu
  fullname: Liu, Dingxi
  organization: Department of Clinical Medicine, Zunyi Medical University
– sequence: 4
  givenname: Libo
  surname: Wang
  fullname: Wang, Libo
  organization: Department of Neurology, China-Japan Union Hospital of Jilin University
– sequence: 5
  givenname: Jia
  surname: Li
  fullname: Li, Jia
  email: lijia33233@jlu.edu.cn
  organization: Department of Neurology, China-Japan Union Hospital of Jilin University
– sequence: 6
  givenname: Xiaoyang
  orcidid: 0009-0005-6184-4869
  surname: Liu
  fullname: Liu, Xiaoyang
  email: liuxy48@jlu.edu.cn
  organization: Department of Neurology, China-Japan Union Hospital of Jilin University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38745316$$D View this record in MEDLINE/PubMed
BookMark eNp9UstuFDEQHKEg8oAf4IBG4sJlwM8d-4RQxGOlIDjA2bI97VmvPPbimYm0OfEPSHwgX4J3N4Qkh5zcsquq21V9Wh3FFKGqnmP0GmOxeDNihAhqEGENQoKIhj-qTjAvBV1wcXSrPq5Ox3Fd0Jgz_qQ6pqJlnOLFSfX7awrbzWobgo_1stYhwKXXE4x1hDknH13Qw6Ann2Kt3QS5tpDBZB1qP9oVDF7_-fkrwwaym8cdysf1nLd1Uamdtj74qbBjX-t5SpuV7rfNAN2uRVd_JvXgbU598EVvk4LO_mrf62n12OkwwrPr86z6_uH9t_NPzcWXj8vzdxeNXTAyNdRRoqnF2HHUGWc0Zq1ArTNAOXNtS6Ux0GHJTCesxYhIgRxDRIBxGjSiZ9XyoNslvVab7Aedtyppr_YXKfdK58nbAEpKIUxHuCneMwpOYMNaaZmWnDDmcNF6e9DazKZ80UKcik13RO--RL9SfbpUGCPJJGuLwqtrhZx-zDBOaigmQwg6QppHRRHnjIlWigJ9eQ-6TnOOxStVchWylZiSgnpxe6SbWf7lXwDkACgpjGMGdwPBSO2WTB2WTJUlU_slU7yQxD2S3Yecdt_y4WEqPVDH0if2kP-P_QDrL4Ff64Q
CitedBy_id crossref_primary_10_1016_j_bbadis_2025_167877
crossref_primary_10_1016_j_brainresbull_2024_111156
crossref_primary_10_1016_j_intimp_2024_113881
crossref_primary_10_1016_j_jep_2025_120402
crossref_primary_10_1016_j_intimp_2025_115365
crossref_primary_10_1016_j_phymed_2025_156771
crossref_primary_10_1007_s12031_025_02414_8
crossref_primary_10_1186_s10020_025_01217_2
crossref_primary_10_3390_biology14091269
crossref_primary_10_1016_j_arr_2025_102866
crossref_primary_10_3389_fphar_2024_1347622
crossref_primary_10_1016_j_pharmthera_2025_108827
crossref_primary_10_1111_cns_70481
crossref_primary_10_1016_j_apsb_2025_07_026
crossref_primary_10_1016_j_prmcm_2025_100641
crossref_primary_10_1186_s12951_025_03576_8
Cites_doi 10.1161/01.STR.0000200561.69611.f8
10.1186/1742-2094-9-96
10.4103/1673-5374.255975
10.1038/cdd.2014.150
10.1038/s41419-018-0902-5
10.1080/15548627.2021.1905466
10.3390/ijms23010014
10.1007/s10753-018-0870-z
10.3390/ijms20030728
10.1080/14786419.2023.2294113
10.1155/2023/5645500
10.1172/jci.insight.131355
10.1073/pnas.1914742117
10.1080/15548627.2023.2167689
10.1016/j.biopha.2023.115653
10.3389/fncel.2023.1182621
10.3389/fcell.2020.616590
10.1096/fj.202001499R
10.1016/j.ejphar.2023.175860
10.1007/s10571-015-0166-x
10.1038/nature07383
10.1126/sciadv.abc5539
10.3390/ijms20133328
10.1016/j.lfs.2020.117624
10.3389/fphar.2023.1145407
10.1016/j.intimp.2020.106547
10.1161/STR.0000000000000375
10.3390/ijms18030598
10.4062/biomolther.2012.089
10.15252/embj.2019103111
10.31083/j.fbs1401003
10.1016/j.pneurobio.2016.05.001
10.1016/j.biopha.2019.109189
10.3389/fimmu.2018.02091
10.1172/JCI64398
10.1111/j.1600-065X.2006.00441.x
10.3390/cells9010070
10.1186/s10020-022-00573-7
10.3389/fphar.2023.1095786
10.1111/bph.13139
10.1016/S2214-109X(13)70089-5
10.1093/jmcb/mjac077
10.3389/fimmu.2021.770744
10.1186/1476-4598-13-43
10.15252/embj.2021108863
10.3390/ijms21186454
10.1038/s12276-021-00570-6
10.21037/atm-20-3371
10.1186/s12974-020-01987-y
10.3390/ijms23169368
10.1038/s41598-017-07194-9
10.3390/ijms18102135
10.4103/1673-5374.346468
10.1186/s12974-019-1644-8
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s10020-024-00828-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
ProQuest Databases
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE

MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1528-3658
EndPage 18
ExternalDocumentID oai_doaj_org_article_9988bd25b11843ef81b479c4a95244f1
PMC11094947
38745316
10_1186_s10020_024_00828_5
Genre Journal Article
GeographicLocations United States--US
China
Japan
GeographicLocations_xml – name: China
– name: United States--US
– name: Japan
GroupedDBID ---
-ET
0R~
123
29M
2WC
36B
5RE
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABUWG
ACGFO
ACMJI
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IH2
IHR
ISR
ITC
KQ8
LGEZI
LOTEE
NADUK
NXXTH
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PUEGO
RBZ
RNS
ROL
RPM
RSV
SDH
SJN
SOJ
SV3
TR2
UKHRP
WOQ
AAYXX
AFFHD
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c642t-3f32a3c11f50dbfba147807fbe354f7739bbed194bd8cc102980f4028ebfaea03
IEDL.DBID DOA
ISICitedReferencesCount 23
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001222569500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1528-3658
1076-1551
IngestDate Fri Oct 03 12:43:23 EDT 2025
Tue Nov 04 02:05:54 EST 2025
Wed Oct 01 14:43:44 EDT 2025
Sun Oct 19 01:28:40 EDT 2025
Thu Apr 03 06:51:55 EDT 2025
Tue Nov 18 21:50:18 EST 2025
Sat Nov 29 02:40:48 EST 2025
Sat Sep 06 07:22:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cerebral ischemia
NLRP3 inflammasome
Microglial polarization
Polyphyllin I (PPI)
Autophagy
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c642t-3f32a3c11f50dbfba147807fbe354f7739bbed194bd8cc102980f4028ebfaea03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0009-0005-6184-4869
OpenAccessLink https://doaj.org/article/9988bd25b11843ef81b479c4a95244f1
PMID 38745316
PQID 3168979132
PQPubID 5066171
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_9988bd25b11843ef81b479c4a95244f1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11094947
proquest_miscellaneous_3055448798
proquest_journals_3168979132
pubmed_primary_38745316
crossref_primary_10_1186_s10020_024_00828_5
crossref_citationtrail_10_1186_s10020_024_00828_5
springer_journals_10_1186_s10020_024_00828_5
PublicationCentury 2000
PublicationDate 2024-05-14
PublicationDateYYYYMMDD 2024-05-14
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-14
  day: 14
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Molecular medicine (Cambridge, Mass.)
PublicationTitleAbbrev Mol Med
PublicationTitleAlternate Mol Med
PublicationYear 2024
Publisher BioMed Central
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: Springer Nature B.V
– name: BMC
References Q Li (828_CR22) 2020; 252
K Xue (828_CR46) 2023; 14
MM Liu (828_CR29) 2021; 19
DO Kleindorfer (828_CR18) 2021; 52
QQ Guo (828_CR9) 2020; 39
X Ye (828_CR48) 2020; 17
A Chamorro (828_CR4) 2006; 37
Q Wang (828_CR39) 2018; 9
A Plaza-Zabala (828_CR34) 2017; 18
N Kelley (828_CR17) 2019; 20
K Fan (828_CR6) 2012; 9
Q Luo (828_CR31) 2022; 23
L Li (828_CR27) 2023; 168
R Li (828_CR26) 2023; 953
T Saitoh (828_CR36) 2008; 456
HE Han (828_CR10) 2013; 21
MY Wu (828_CR42) 2019; 9
AM Sun (828_CR37) 2023; 2023
DY Xia (828_CR43) 2021; 12
RH Tang (828_CR38) 2019; 14
L Li (828_CR25) 2023
F Zheng (828_CR51) 2023; 14
Z Zhu (828_CR54) 2019; 20
Z Yu (828_CR49) 2022; 28
R Orihuela (828_CR33) 2016; 173
CD Maida (828_CR32) 2020; 21
XY Xiong (828_CR45) 2016; 142
J Zang (828_CR50) 2020; 8
J Li (828_CR24) 2023; 14
A Al Mamun (828_CR1) 2020; 117
N Hegdekar (828_CR13) 2023; 19
RV Krishnamurthi (828_CR20) 2013; 1
C Fu (828_CR8) 2020; 84
M Yang (828_CR47) 2014; 13
M Kanazawa (828_CR16) 2017; 18
T He (828_CR12) 2020; 17
L Lin (828_CR28) 2016; 5
Y Zhou (828_CR53) 2020; 34
MJ Carson (828_CR3) 2006; 213
L Li (828_CR21) 2015; 35
W Liu (828_CR30) 2021; 17
H Wang (828_CR40) 2023; 17
T Zhu (828_CR55) 2019; 42
J He (828_CR11) 2019; 117
R Huang (828_CR14) 2020; 8
T Xiao (828_CR44) 2018; 9
W Cai (828_CR2) 2019; 4
X Li (828_CR23) 2021; 7
HY Ryu (828_CR35) 2021; 53
A Jurcau (828_CR15) 2021; 23
G Filomeni (828_CR7) 2015; 22
J Chang (828_CR5) 2017; 7
J Zhou (828_CR52) 2013; 123
SG Zubova (828_CR56) 2022; 14
DJ Klionsky (828_CR19) 2021; 40
SY Wang (828_CR41) 2023; 18
References_xml – volume: 37
  start-page: 291
  issue: 2
  year: 2006
  ident: 828_CR4
  publication-title: Stroke
  doi: 10.1161/01.STR.0000200561.69611.f8
– volume: 9
  start-page: 96
  year: 2012
  ident: 828_CR6
  publication-title: J Neuroinflamm
  doi: 10.1186/1742-2094-9-96
– volume: 14
  start-page: 1594
  issue: 9
  year: 2019
  ident: 828_CR38
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.255975
– volume: 22
  start-page: 377
  issue: 3
  year: 2015
  ident: 828_CR7
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2014.150
– volume: 9
  start-page: 906
  issue: 9
  year: 2018
  ident: 828_CR44
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0902-5
– volume: 17
  start-page: 4159
  issue: 12
  year: 2021
  ident: 828_CR30
  publication-title: Autophagy
  doi: 10.1080/15548627.2021.1905466
– volume: 23
  start-page: 14
  issue: 1
  year: 2021
  ident: 828_CR15
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23010014
– volume: 42
  start-page: 35
  issue: 1
  year: 2019
  ident: 828_CR55
  publication-title: Inflammation
  doi: 10.1007/s10753-018-0870-z
– volume: 20
  start-page: 728
  issue: 3
  year: 2019
  ident: 828_CR54
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20030728
– year: 2023
  ident: 828_CR25
  publication-title: Nat Prod Res
  doi: 10.1080/14786419.2023.2294113
– volume: 2023
  start-page: 5645500
  year: 2023
  ident: 828_CR37
  publication-title: Evid Based Complement Altern Med Ecam
  doi: 10.1155/2023/5645500
– volume: 4
  issue: 20
  year: 2019
  ident: 828_CR2
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.131355
– volume: 117
  start-page: 1742
  issue: 3
  year: 2020
  ident: 828_CR1
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1914742117
– volume: 19
  start-page: 2026
  issue: 7
  year: 2023
  ident: 828_CR13
  publication-title: Autophagy
  doi: 10.1080/15548627.2023.2167689
– volume: 168
  year: 2023
  ident: 828_CR27
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2023.115653
– volume: 17
  start-page: 1182621
  year: 2023
  ident: 828_CR40
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2023.1182621
– volume: 8
  year: 2020
  ident: 828_CR50
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2020.616590
– volume: 34
  start-page: 16414
  issue: 12
  year: 2020
  ident: 828_CR53
  publication-title: FASEB J
  doi: 10.1096/fj.202001499R
– volume: 953
  year: 2023
  ident: 828_CR26
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2023.175860
– volume: 35
  start-page: 615
  issue: 5
  year: 2015
  ident: 828_CR21
  publication-title: Cell Mol Neurobiol
  doi: 10.1007/s10571-015-0166-x
– volume: 456
  start-page: 264
  issue: 7219
  year: 2008
  ident: 828_CR36
  publication-title: Nature
  doi: 10.1038/nature07383
– volume: 7
  start-page: eabc5539
  issue: 4
  year: 2021
  ident: 828_CR23
  publication-title: Sci Adv
  doi: 10.1126/sciadv.abc5539
– volume: 20
  start-page: 3328
  issue: 13
  year: 2019
  ident: 828_CR17
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20133328
– volume: 252
  year: 2020
  ident: 828_CR22
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.117624
– volume: 14
  start-page: 1145407
  year: 2023
  ident: 828_CR51
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2023.1145407
– volume: 84
  year: 2020
  ident: 828_CR8
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2020.106547
– volume: 52
  start-page: e364
  issue: 7
  year: 2021
  ident: 828_CR18
  publication-title: Stroke
  doi: 10.1161/STR.0000000000000375
– volume: 18
  start-page: 598
  issue: 3
  year: 2017
  ident: 828_CR34
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18030598
– volume: 21
  start-page: 21
  issue: 1
  year: 2013
  ident: 828_CR10
  publication-title: Biomol Ther (seoul)
  doi: 10.4062/biomolther.2012.089
– volume: 39
  issue: 10
  year: 2020
  ident: 828_CR9
  publication-title: EMBO J
  doi: 10.15252/embj.2019103111
– volume: 14
  start-page: 3
  issue: 1
  year: 2022
  ident: 828_CR56
  publication-title: Front Biosci (schol Ed)
  doi: 10.31083/j.fbs1401003
– volume: 142
  start-page: 23
  year: 2016
  ident: 828_CR45
  publication-title: Prog Neurobiol
  doi: 10.1016/j.pneurobio.2016.05.001
– volume: 117
  year: 2019
  ident: 828_CR11
  publication-title: Biomed Pharmacother Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109189
– volume: 9
  start-page: 2091
  year: 2018
  ident: 828_CR39
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02091
– volume: 123
  start-page: 1821
  issue: 4
  year: 2013
  ident: 828_CR52
  publication-title: J Clin Invest
  doi: 10.1172/JCI64398
– volume: 213
  start-page: 48
  year: 2006
  ident: 828_CR3
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.2006.00441.x
– volume: 9
  start-page: 70
  issue: 1
  year: 2019
  ident: 828_CR42
  publication-title: Cells
  doi: 10.3390/cells9010070
– volume: 28
  start-page: 142
  issue: 1
  year: 2022
  ident: 828_CR49
  publication-title: Mol Med
  doi: 10.1186/s10020-022-00573-7
– volume: 5
  start-page: 213
  issue: 4
  year: 2016
  ident: 828_CR28
  publication-title: Biochem Pharmacol (los Angel)
– volume: 14
  start-page: 1095786
  year: 2023
  ident: 828_CR24
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2023.1095786
– volume: 173
  start-page: 649
  issue: 4
  year: 2016
  ident: 828_CR33
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13139
– volume: 1
  start-page: e259
  issue: 5
  year: 2013
  ident: 828_CR20
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(13)70089-5
– volume: 14
  start-page: mjac077
  issue: 12
  year: 2023
  ident: 828_CR46
  publication-title: J Mol Cell Biol
  doi: 10.1093/jmcb/mjac077
– volume: 12
  year: 2021
  ident: 828_CR43
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.770744
– volume: 13
  start-page: 43
  year: 2014
  ident: 828_CR47
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-43
– volume: 40
  issue: 19
  year: 2021
  ident: 828_CR19
  publication-title: EMBO J
  doi: 10.15252/embj.2021108863
– volume: 21
  start-page: 6454
  issue: 18
  year: 2020
  ident: 828_CR32
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21186454
– volume: 53
  start-page: 369
  issue: 3
  year: 2021
  ident: 828_CR35
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-021-00570-6
– volume: 8
  start-page: 644
  issue: 10
  year: 2020
  ident: 828_CR14
  publication-title: Ann Transl Med
  doi: 10.21037/atm-20-3371
– volume: 17
  start-page: 329
  issue: 1
  year: 2020
  ident: 828_CR12
  publication-title: J Neuroinflamm
  doi: 10.1186/s12974-020-01987-y
– volume: 23
  start-page: 9368
  issue: 16
  year: 2022
  ident: 828_CR31
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23169368
– volume: 7
  start-page: 7605
  issue: 1
  year: 2017
  ident: 828_CR5
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-07194-9
– volume: 18
  start-page: 2135
  issue: 10
  year: 2017
  ident: 828_CR16
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18102135
– volume: 18
  start-page: 434
  issue: 2
  year: 2023
  ident: 828_CR41
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.346468
– volume: 19
  start-page: 255
  issue: 4
  year: 2021
  ident: 828_CR29
  publication-title: Chin J Nat Med
– volume: 17
  start-page: 18
  issue: 1
  year: 2020
  ident: 828_CR48
  publication-title: J Neuroinflamm
  doi: 10.1186/s12974-019-1644-8
SSID ssj0021545
Score 2.5204935
Snippet Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from...
Abstract Microglial activation and polarization play a central role in poststroke inflammation and neuronal damage. Modulating microglial polarization from...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 59
SubjectTerms Animals
Apoptosis
Autophagy
Autophagy - drug effects
Biomedical and Life Sciences
Biomedicine
Brain
Brain Ischemia - drug therapy
Brain Ischemia - metabolism
Cancer
Carotid arteries
Cell Polarity - drug effects
Cerebral ischemia
Cytokines
Diosgenin - analogs & derivatives
Diosgenin - pharmacology
Diosgenin - therapeutic use
Disease Models, Animal
Infarction, Middle Cerebral Artery - drug therapy
Inflammation
Ischemia
Male
Mice
Mice, Inbred C57BL
Microglia - drug effects
Microglia - metabolism
Microglial polarization
Molecular Medicine
Neuroinflammatory Diseases - drug therapy
Neuroinflammatory Diseases - etiology
Neuroinflammatory Diseases - metabolism
NLRP3 inflammasome
Polyphyllin I (PPI)
Reperfusion Injury - drug therapy
Reperfusion Injury - etiology
Reperfusion Injury - metabolism
Research Article
Signal Transduction - drug effects
Stroke
Surgery
Tissues
TOR Serine-Threonine Kinases - metabolism
Veins & arteries
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELagCxIX3o_AgozEDSyS2IntE2LRruBAtUIg7S2yHbsEddOStiv1xn9A4gfyS5hx0q7KYy9cEydyMjP2fLbn-wh5BpgjM6aWLK15yoTwnmkJmKeU2sssD6XiJopNyPFYnZzo42HBbTEcq9yMiXGgrmcO18hfosCSlhrA06v5V4aqUbi7OkhoXCZ7yFQmRmTv4HB8_GELuTBB6E8dlgyTg03ZjCqxeA6hE8xRLPK4sWJnaooM_n9LO_88PfnbFmqcmY5u_O833STXh5yUvu6d6Ba55Nvb5GqvUrm-Q34cz6ZrsAayd9N3FMVXzhpMUWkkwwQXBa_qKyBplBynzne4Hz2lDWBnf9qYn9--d37uu7DCxTnatF_AlBTeQoNxA094O6FmhTQHZrJmsaAFkmH6PqeneGZwMoVAoXME4kPl6F3y6ejw45u3bJBzYA5AzpLxwHPDXZaFIq1tsCYTUqUyWM8LEaTk2lpfgxVtrZzLkBs-DQBvlbfBeJPye2TUzlr_gFAVRKlKmXPngwCAaYs81LqoeeG1sbJMSLaxZOUGrnOU3JhWEfOosuqtX4H1q2j9qkjI8-0z857p48LWB-gg25bI0h0vzLpJNQR9BVBW2TovbIaqOj4ARBBSO2F0AVlVyBKyv_GLahg6FtW5UyTk6fY2BD3u5JjWz1bQJoUsEKCmVgm533vjticcBQzgJQlRO36609XdO23zORKLI_us0EIm5MXGpc_79e9_8fDiz3hEruUxygqWiX0yWnYr_5hccWfLZtE9GSL2F55ZS00
  priority: 102
  providerName: ProQuest
– databaseName: SpringerLINK Contemporary 1997-Present
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLVgAIkN70dgQEZiB5Hi2IntJSBGsGA04qXZWXZil6BOWqXtSN3xD0h8IF_Cvc4DFQYk2DZOZN2cG99T-55DyGPgHMzaWqZZzbNUCO9TLYHzlFJ7yfJQKm6j2YQ8PFTHx_poaApbjafdxy3J-KWOaa1KbHZDqgNrShp119LiPLkAy53CdHz77uNEs7AoGNtjzrxvZwmKSv1nlZe_n5L8Zas0rkAHV_9v7tfIlaHipM96iFwn53x7g1zqPSi3N8m3o8V8C7FGbW76mqK1ymmDBSiNUpcAQMBM399Io6E4rXyHu81z2gAz9ieN_f7la-eXvgsb_OuNNu1neFEUnkKDrQYV8HZG7QZFDOxsm8Z2FSh16ZucnuCJwNkc0oAukWYPfaG3yIeDl-9fvEoHs4a0AgqzTnngueUVY6HIahecZUKqTAbneSGClFw752umhatVVTFUfs8CkFflXbDeZvw22WsXrb9LqAqiVKXMeeWDAProijzUuqh54bV1skwIG9-fqQYlczTUmJvIaFRp-ngbiLeJ8TZFQp5M9yx7HY-_jn6OsJhGogZ3_GHRzcyQ0gaIqnJ1XjiGnjk-AAEQUlfC6gJqpsASsj-CygwfhpVBnzAtNeN5Qh5NlyGlcZ_Gtn6xgTEZ1HhAJLVKyJ0eg9NMONoTwEMSonbQuTPV3Stt8ynKhqO2rNBCJuTpCNKf8_pzLO792_D75HIecV6kTOyTvXW38Q_Ixep03ay6hzFTfwA1aj4C
  priority: 102
  providerName: Springer Nature
Title Polyphyllin I alleviates neuroinflammation after cerebral ischemia–reperfusion injury via facilitating autophagy-mediated M2 microglial polarization
URI https://link.springer.com/article/10.1186/s10020-024-00828-5
https://www.ncbi.nlm.nih.gov/pubmed/38745316
https://www.proquest.com/docview/3168979132
https://www.proquest.com/docview/3055448798
https://pubmed.ncbi.nlm.nih.gov/PMC11094947
https://doaj.org/article/9988bd25b11843ef81b479c4a95244f1
Volume 30
WOSCitedRecordID wos001222569500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: Open Access: BioMedCentral Open Access Titles
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1528-3658
  databaseCode: RBZ
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1528-3658
  databaseCode: DOA
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1528-3658
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1528-3658
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1528-3658
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1528-3658
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LjtMwFL2CASQ2iDeBoTISO4hIYie2lwyaEbOYUTU8VFaRndidoE5addqRuuMfkPhAvoR7nbRQnhs2kZK4keV7LN9T-54D8BQ5R2pMLeOk5kkshHOxlsh5CqmdTDNfKG6C2YQ8PlajkR7-YPVFZ8I6eeBu4F4gHVC2znKbkjOJ85hmCakrYXSOK5MPxAeznjWZ6qkWJQbrEhlVUKEc0SRcj-Kg2RbnW8tQUOv_XYr560nJn7ZLwyp0cBNu9Okje9l1-xZccu1tuNYZSq7uwJfhdLLCgSOhbXbIyCfloqFskgXdSkQTAqArVmTBHZxVbk5bxxPWIM11Z435-unz3M3c3C_pfzTWtB9x1Bl-hXlT9ZLe7ZiZJSkSmPEqDrUnmLeyo4yd0fG-8QQxzWbEmfsiz7vw7mD_7avXce-8EFfIRxYx9zwzvEpTnye19dakQqpEeut4LryUXFvr6lQLW6uqSknGPfHIRJWz3jiT8Huw005b9wCY8qJQhcx45bxALmjzzNc6r3nutLGyiCBdB6KsellycseYlIGeqKLsgldi8MoQvDKP4NnmN7NOlOOvrfcovpuWJKgdHiDMyh5m5b9gFsHuGh1lP8vPSzL90lIjoY_gyeY1zk_adDGtmy6xTYIJG7JCrSK434Fp0xNOXgP4kQjUFsy2urr9pm1OgwY4CcUKLWQEz9eI_N6vP4_Fw_8xFo_gehamUh6nYhd2FvOlewxXq4tFcz4fwGU5kuGqBnBlb_94eDIIkxPvhodHww94d_Lm_Tdidj9L
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbhMxFLVKAcGG92OggJFgBRbztr1AiFfVqG3URZG6G2yPHYLCJEySouz4ByQ-g4_iS7jXM5MoPLrrgu2MY3mce6_vsX3PIeQRYI5IqZKzsExClqbWMskB8-RcWh7FLheJ8mITvN8XR0fyYIP86Gph8FplFxN9oC7HBvfIn6HAkuQSwNOLyWeGqlF4utpJaDRmsWsXXwCyTZ_33sD_-ziOt98evt5hraoAM5Brz1jiklglJopcFpbaaRWlXITcaZtkqeM8kVrbErC9LoUxEVKUhw5QlrDaKavCBPo9Q85CHOd4hYwfrQAepiPNHcecYSrSFemIHEv1EKjBisg8axzL1hZCrxfwtyT3z7uavx3Y-nVw-_L_NoNXyKU246YvGxe5SjZsdY2cbzQ4F9fJ94PxaAG2htzktEdRWuZ4iAk49VSf4IDgM019J_WC6tTYGk_bR3Q4NUi3oH5-_Vbbia3dHLce6bD6CIZKoRfqlGlZ0KsBVXMkcVCDBfPlOpDq0_2YfsIbkYMRhAE6wW2Gti72Bnl3KpNyk2xW48reJlS4NBc5jxNjXQrwWWexK2VWJpmVSvM8IFFnOYVpmdxRUGRUeEQn8qKxtgKsrfDWVmQBebL8zaThMTmx9Ss0yGVL5CD3D8b1oGhDWgFAXegyznSEmkHWAQBKuTSpkhnkjC4KyFZnh0UbGKfFyggD8nD5GkIanlOpyo7n0CaEHBeAtBQBudVY_3IkCcozQCcBEWt-sTbU9TfV8IOnTUdu3VSmPCBPOxdajevfc3Hn5M94QC7sHO7vFXu9_u5dcjH2Hp6xKN0im7N6bu-Rc-Z4NpzW932soOT9abvWL1tcqI4
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LjtMwFLWGGUBseD8CAxgJVmBNHk5sLxAChopqmKoLkIZVxnHsUlTS0seg7vgHJD6Gz-FLuNdJOiqP2c2CbeJajnvv9T227zmEPATMEWldChaWScg4t5YpAZgnE8qKKHaZTLQXmxC9njw4UP0N8qOthcFrlW1M9IG6HBvcI99BgSUlFICnHddci-jvdp5NPjNUkMKT1lZOozaRPbv8AvBt9rS7C__1ozjuvHr78jVrFAaYgbx7zhKXxDoxUeTSsCxcoSMuZChcYZOUOyESVRS2BJxflNKYCOnKQweIS9rCaavDBPo9Q7YgJefgY1v97n7__QruYXJS33jMGCYmbcmOzLBwD2EbrI_Mc8ixdG1Z9OoBf0t5_7y5-dvxrV8VO5f-5_m8TC42uTh9XjvPFbJhq6vkXK3OubxGvvfHoyVYIbKW0y5F0ZmjIabm1JOAgmuCN9WVn9RLrVNjp3gOP6LDmUEiBv3z67epndipW-CmJB1WH8GEKfRCnTYNP3o1oHqB9A56sGS-kAdAAN2P6Se8KzkYQYCgE9yAaCpmr5N3pzIpN8hmNa7sLUKl45nMRJwY6zgA6yKNXanSMkmt0oXIAhK1VpSbhuMdpUZGucd6Mstry8vB8nJveXkakMer30xqhpMTW79A41y1RHZy_2A8HeRNsMsBwsuijNMiQjUh6wAacaEM1yqFbNJFAdlubTJvQuYsPzbIgDxYvYZghydYurLjBbQJIfsFiK1kQG7WnrAaSYLCDdBJQOSaj6wNdf1NNfzgCdWRdZcrLgLypHWn43H9ey5un_wZ98l58Kj8Tbe3d4dciL2zpyzi22RzPl3Yu-SsOZoPZ9N7TeCg5PC0fesXVpSy3Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polyphyllin+I+alleviates+neuroinflammation+after+cerebral+ischemia-reperfusion+injury+via+facilitating+autophagy-mediated+M2+microglial+polarization&rft.jtitle=Molecular+medicine+%28Cambridge%2C+Mass.%29&rft.au=Kang%2C+Chunyang&rft.au=Sang%2C+Qiuling&rft.au=Liu%2C+Dingxi&rft.au=Wang%2C+Libo&rft.date=2024-05-14&rft.eissn=1528-3658&rft.volume=30&rft.issue=1&rft.spage=59&rft_id=info:doi/10.1186%2Fs10020-024-00828-5&rft_id=info%3Apmid%2F38745316&rft.externalDocID=38745316
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-3658&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-3658&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-3658&client=summon